These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15918203)

  • 21. Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment.
    Zampino R; Marrone A; Cirillo G; del Giudice EM; Utili R; Karayiannis P; Liang TJ; Ruggiero G
    J Viral Hepat; 2002 May; 9(3):183-8. PubMed ID: 12010505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of mutations in basal core promoter and precore region of hepatitis B virus in vaccinated and nonvaccinated individuals of the aboriginal Nicobarese tribe of Car Nicobar Island, India.
    Bhattacharya H; Bhattacharya D; Nagarajan M; Reesu R; Roy S; Attayur PS
    Intervirology; 2014; 57(6):357-64. PubMed ID: 25323975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels.
    Shi M; Zhang Y; Zhang J; Liu W; Xing L
    Braz J Infect Dis; 2012; 16(1):52-6. PubMed ID: 22358356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
    J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.
    Nian X; Xu Z; Liu Y; Chen J; Li X; Xu D
    Hepatol Int; 2016 Jul; 10(4):606-15. PubMed ID: 26984835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.
    Gao S; Joshi SS; Osiowy C; Chen Y; Coffin CS; Duan ZP
    Virol J; 2017 Oct; 14(1):203. PubMed ID: 29065883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.
    Seo Y; Yoon S; Nakaji M; Yano Y; Nagano H; Ninomiya T; Hayashi Y; Kasuga M
    Intervirology; 2003; 46(1):43-9. PubMed ID: 12566698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection.
    Marrone A; Zampino R; Luongo G; Utili R; Karayiannis P; Ruggiero G
    Intervirology; 2003; 46(4):222-6. PubMed ID: 12931030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.
    Yan L; Zhang H; Ma H; Liu D; Li W; Kang Y; Yang R; Wang J; He G; Xie X; Wang H; Wei L; Lu Z; Shao Q; Chen H
    Sci Rep; 2015 Dec; 5():17950. PubMed ID: 26647737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.
    Zhang D; Ma S; Zhang X; Zhao H; Ding H; Zeng C
    BMC Infect Dis; 2010 Sep; 10():271. PubMed ID: 20846420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
    Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
    J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe.
    Bläckberg J; Kidd-Ljunggren K
    J Med Virol; 2000 Feb; 60(2):107-12. PubMed ID: 10596007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new hepatitis B virus e antigen-negative strain gene used as a reference sequence in an animal model.
    Cao M; Zhao Z; Tang Y; Wei Q; Wang L; Xiang Q; Zhang Y; Zhang H; Lai G
    Biochem Biophys Res Commun; 2018 Feb; 496(2):502-507. PubMed ID: 29339154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.